Skip to main content
Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc. — Investor Relations & Filings

Ticker · SPRO ISIN · US84833T1034 LEI · 54930074G13LHWJT2323 US Manufacturing
Open in API
Filings indexed 481 across all filing types
Latest filing 2020-11-05 Interim / Quarterly Rep…
Country US United States of America
Listing US SPRO

About Spero Therapeutics, Inc.

https://sperotherapeutics.com/

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections. The company's primary mission is to address the significant unmet medical needs caused by antibiotic resistance. Its pipeline includes tebipenem HBr, an oral carbapenem antibiotic candidate for the treatment of complicated urinary tract infections (cUTIs), which has completed a Phase 3 trial. Spero Therapeutics leverages its expertise in chemistry and microbiology, alongside strategic partnerships, to advance its portfolio of innovative therapies for serious infections.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2020
2020-11-05 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated October 27, 2020, reporting on the submission of matters to a vote of stockholders at the company's 2020 annual meeting. It details the voting results for director elections and the ratification of the independent auditor. The content focuses on the official results of shareholder votes at the annual meeting. The document length is 3655 characters, which is relatively short and consistent with a voting results announcement rather than a full report. There is no financial data or detailed report content, only voting outcomes. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-10-28 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-27 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-27 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-27 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-27 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.